RxDoctor Payments Data

Evan Hewgley, PA

Physician Assistant · Newport, TNNPI 1386066694

Payments from drug & device makers

$2,339in general payments, 2019–2025

Across 143 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$433
  • GSK$259
  • Novo Nordisk$248
  • AstraZeneca$220
  • Lilly USA, LLC$219
  • Pfizer$165
  • plus $795 from 17 others

What the payments were for

  • Food & beverage$2,339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,339 in reported general payments places this provider in the 80th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$70,693
Medicare patients
104
Services billed
2,237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tresiba Flextouch U-200Insulin Degludec36$76,829
EliquisApixaban51$48,199
MounjaroTirzepatide33$45,748
Breztri AerosphereBudesonide/Glycopyr/Formoterol45$43,204
FarxigaDapagliflozin Propanediol38$39,291
RybelsusSemaglutide32$38,990
OzempicSemaglutide21$37,928
JardianceEmpagliflozin30$36,949
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$31,313
EntrestoSacubitril/Valsartan19$16,811
MyrbetriqMirabegron20$13,575
Bevespi AerosphereGlycopyrrolate/Formoterol Fum13$13,493
Repatha SureclickEvolocumab20$10,874
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$6,288
Novolog FlexpenInsulin Aspart19$6,005

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga, Bevespi Aerosphere, Symbicort$220$99,459108 claims
Novo NordiskRybelsus, Ozempic$248$76,91853 claims
PfizerEliquis$165$48,19951 claims
Lilly USA, LLCMounjaro$219$45,74833 claims
Boehringer IngelheimJardiance$45$36,94930 claims
GSKTrelegy Ellipta$259$31,31323 claims
NovartisEntresto$28$16,81119 claims
Astellas Pharma US IncMyrbetriq$50$13,57520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Newport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →